Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Baptist Health South Florida
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
Case Comprehensive Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
University of Pennsylvania
Mayo Clinic
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of Pennsylvania
University of Pennsylvania
University of Illinois at Chicago
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China